Polar Capital Holdings plc (Polar Capital), the specialist active asset management group, is to rename its Healthcare Blue Chip Fund as the Polar Capital Global Healthcare Select Fund.
The name change is to better reflect the Fund’s long‑standing, high‑conviction investment approach and the breadth of opportunities it targets across the global healthcare sector.
The Global Healthcare Select Fund is a concentrated portfolio of 25-40 stocks, constructed through detailed bottom‑up research. The portfolio has meaningful exposure to small and mid-cap healthcare companies alongside established global leaders, rather than being limited to the largest names in the index.
The Fund’s focus is to build a carefully curated, high-conviction portfolio based on stock selection across healthcare subsectors and market caps.
Investors are increasingly seeking high-conviction, actively managed funds that provide targeted exposure to sectors with strong growth potential. With the healthcare industry undergoing transformative changes, driven by demographic shifts, accelerated biotech innovation and the growing demand for personalised medicine, the Polar Capital Global Healthcare Select Fund is uniquely positioned to capitalise on these long-term structural trends by focusing on both established leaders and innovative small to mid-cap companies.
James Douglas, Fund Manager of Polar Capital Global Healthcare Select Fund said: “This is not a change in investment strategy. The Fund has always been managed as a focused, actively managed portfolio and we have full conviction in the investment proposition. The new name more accurately reflects how we invest and the types of opportunity we seek within the healthcare universe.”
The Fund continues to be managed by Polar Capital’s specialist healthcare investment team, with an emphasis on fundamental analysis, disciplined portfolio construction and risk awareness. The team believes the healthcare sector currently presents compelling opportunities, supported by long‑term structural drivers such as demographic change, ongoing innovation and the essential nature of healthcare spending globally.
The name change does not affect the Fund’s investment objective, benchmark or portfolio management team. Existing investors will experience no change to how the Fund is managed.
For further information, please contact:
Camarco
Louise Dolan: 07446 870 025 / louise.dolan@camarco.co.uk
Annabel Reed: 07969 273049 / annabel.reed@camarco.co.uk
About Polar Capital
Polar Capital is a specialist, investment-led, active fund manager. With a collegiate and meritocratic culture where capacity of investment strategies is managed to enhance and protect performance. Since its foundation in 2001, it has grown steadily and currently has 13 autonomous investment teams managing specialist, active and capacity constrained portfolios, with combined AUM of £30.6bn (as of 31 March 2026).
Polar Capital is principally located in London and maintains offices in the UK, France, Spain, Germany, Switzerland, the US and China and Singapore.
Polar Capital LLP is authorised and regulated by the UK Financial Conduct Authority and registered as an investment adviser with the US Securities and Exchange Commission.
